Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v4-FR Version v1-EN
Language French English
Date Updated 2020-09-21 2020-09-18
Drug Identification Number Not Applicable/non applicable Not Applicable/non applicable
Brand name THALLOUS CHLORIDE TI 201 INJECTION THALLOUS CHLORIDE TI 201 INJECTION
Common or Proper name Thallous Chloride TI 201 Thallous Chloride TI 201
Company Name GE HEALTHCARE CANADA INC GE HEALTHCARE CANADA INC
Ingredients THALLIUM CHLORIDE THALLIUM CHLORIDE
Strength(s) 37MBq 37MBq
Dosage form(s) SOLUTION SOLUTION
Route of administration INTRAVENOUS INTRAVENOUS INTRAVENOUS INTRAVENOUS
Packaging size 8.8 mL 8.8 mL
ATC code V09GX V09GX
ATC description
Reason for shortage Disruption of the manufacture of the drug. Disruption of the manufacture of the drug.
Anticipated start date
Actual start date 2020-09-15 2020-09-15
Estimated end date 2020-09-20 2020-09-20
Actual end date 2020-09-20
Shortage status Resolved Actual shortage
Tier 3 Status No No
Company comments
Health Canada comments